CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 382,506	$ 466,325
Short-term investments	12,112	13,206
Accounts receivable, net of allowance of $6,513 and $6,098, respectively	125,241	73,605
ACO REACH performance year receivable	882,884	99,181
Current assets of discontinued operations (Note 16)	2,225,739	2,783,474
Prepaids and other current assets	142,932	134,843
Total current assets	3,771,414	3,570,634
Other assets:
Long-term investments	3,816	5,401
Property, equipment and capitalized software, net	40,747	42,596
Goodwill	760,078	760,078
Intangible assets, net	242,286	249,083
Other non-current assets	29,664	37,260
Total other assets	1,076,591	1,094,418
Total assets	4,848,005	4,665,052
Current liabilities:
Medical costs payable	458,465	411,753
Accounts payable	33,638	67,854
Unearned revenue	139,416	242
ACO REACH performance year obligation	719,420	0
Short-term borrowings	303,947	303,947
Current liabilities of discontinued operations (Note 16)	2,225,739	2,783,474
Other current liabilities	131,256	121,424
Total current liabilities	4,011,881	3,688,694
Other liabilities	32,191	36,673
Total liabilities	4,044,072	3,725,367
Commitments and contingencies (Note 11)
Redeemable noncontrolling interests	223,503	219,758
Redeemable Series A preferred stock, $0.0001 par value; 750,000 shares authorized in 2023 and 2022; 750,000 shares issued and outstanding in 2023 and 2022	920,417	920,417
Shareholders’ equity (deficit):
Common stock, $0.0001 par value; 3,000,000,000 shares authorized in 2023 and 2022; 636,142,597 and 630,271,508 shares issued and outstanding in 2023 and 2022, respectively	63	63
Additional paid-in capital	3,005,592	2,972,271
Accumulated deficit	(3,331,406)	(3,156,395)
Accumulated other comprehensive loss	(2,236)	(4,429)
Treasury Stock, at cost, 2,522,148 shares at March 31, 2023, and December 31, 2022, respectively	(12,000)	(12,000)
Total shareholders’ equity (deficit)	(339,987)	(200,490)
Total liabilities, redeemable noncontrolling interests, redeemable preferred stock and shareholders’ equity (deficit)	4,848,005	4,665,052
Redeemable Series A preferred stock
Current liabilities:
Redeemable Series A preferred stock, $0.0001 par value; 750,000 shares authorized in 2023 and 2022; 750,000 shares issued and outstanding in 2023 and 2022	747,481	747,481
Redeemable Series B preferred stock
Current liabilities:
Redeemable Series A preferred stock, $0.0001 par value; 750,000 shares authorized in 2023 and 2022; 750,000 shares issued and outstanding in 2023 and 2022	$ 172,936	$ 172,936